Should we be initiating antiretroviral therapy earlier? An argument in favour

S Afr Med J. 2005 Dec;95(12):926, 928.
No abstract available

MeSH terms

  • Anti-Retroviral Agents / administration & dosage*
  • CD4 Lymphocyte Count
  • Drug Administration Schedule
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • HIV Infections / mortality
  • Health Policy*
  • Humans
  • Practice Guidelines as Topic
  • South Africa

Substances

  • Anti-Retroviral Agents